BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2142234)

  • 1. Effect of toremifene on the activity of NK-cells in NZB/NZW mice.
    Wärri A; Kangas L
    J Steroid Biochem; 1990 Jun; 36(3):207-9. PubMed ID: 2142234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Additive and synergistic effects of a novel antiestrogen, toremifene (Fc-1157a), and human interferons on estrogen responsive MCF-7 cells in vitro.
    Kangas L; Nieminen AL; Cantell K
    Med Biol; 1985; 63(4):187-90. PubMed ID: 2419713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of toremifene on estrogen primed vaginal mucosa in postmenopausal women.
    Mäenpää J; Söderström KO; Grönroos M; Taina E; Hajba A; Kangas L
    J Steroid Biochem; 1990 Jun; 36(3):221-3. PubMed ID: 2142237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of hormone-dependent and independent breast cancer cell growth in vivo and in vitro with the antiestrogen toremifene and recombinant human interferon-alpha 2.
    Robinson SP; Goldstein D; Witt PL; Borden EC; Jordan VC
    Breast Cancer Res Treat; 1990 Feb; 15(2):95-101. PubMed ID: 2138919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of the pharmacological properties of toremifene.
    Kangas L
    J Steroid Biochem; 1990 Jun; 36(3):191-5. PubMed ID: 2142231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiestrogenic and antitumor properties of the new triphenylethylene derivative toremifene in the rat.
    di Salle E; Zaccheo T; Ornati G
    J Steroid Biochem; 1990 Jun; 36(3):203-6. PubMed ID: 2142233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additive and synergistic antitumor effects with toremifene and interferons.
    Kangas L; Cantell K; Schellekens H
    J Steroid Biochem; 1990 Jun; 36(3):259-62. PubMed ID: 2142249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiestrogenic action of toremifene on hormone-dependent, -independent, and heterogeneous breast tumor growth in the athymic mouse.
    Robinson SP; Jordan VC
    Cancer Res; 1989 Apr; 49(7):1758-62. PubMed ID: 2522347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen suppression of erbB2 expression is associated with increased growth rate of ZR-75-1 human breast cancer cells in vitro and in nude mice.
    Wärri AM; Laine AM; Majasuo KE; Alitalo KK; Härkönen PL
    Int J Cancer; 1991 Oct; 49(4):616-23. PubMed ID: 1680817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of the stimulatory effect of estrogens, OH-tamoxifen, OH-toremifene, droloxifene, and raloxifene on alkaline phosphatase activity by the antiestrogen EM-800 in human endometrial adenocarcinoma Ishikawa cells.
    Simard J; Sanchez R; Poirier D; Gauthier S; Singh SM; Merand Y; Belanger A; Labrie C; Labrie F
    Cancer Res; 1997 Aug; 57(16):3494-7. PubMed ID: 9270018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toremifene as an anticancer agent.
    Jordan VC
    Cancer Invest; 1990; 8(2):271. PubMed ID: 2144785
    [No Abstract]   [Full Text] [Related]  

  • 12. [The anti-estrogenic effect of 4-chloro-1,2-diphenyl-1-(4-[2-(N,N-dimethylamino)ethoxy]phenyl)1-butene (Toremifene) on the endocrine regulation in breast cancer patients].
    Számel I; Hindy I; Vincze B; Ady N; Eckhardt S
    Orv Hetil; 1991 Mar; 132(13):683-6. PubMed ID: 1826556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormonal effects of toremifene in breast cancer patients.
    Számel I; Vincze B; Hindy I; Kerpel-Fronius S; Eckhardt S; Mäenpää J; Grönroos M; Kangas L; Sundquist H; Hajba A
    J Steroid Biochem; 1990 Jun; 36(3):243-7. PubMed ID: 2142246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy of the SL2-5 murine lymphoma with natural killer cells and tamoxifen or toremifene.
    Baral E; Nagy E; Kangas L; Berczi I
    Anticancer Res; 1997; 17(1A):77-83. PubMed ID: 9066633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of toremifene in breast cancer patients. Preliminary communication.
    Hindy I; Juhos E; Szántó J; Számel I
    J Steroid Biochem; 1990 Jun; 36(3):225-6. PubMed ID: 2142238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The oestrogen antagonists, tamoxifen and FC-1157a, display oestrogen like effects on human lymphocyte functions in vitro.
    Paavonen T; Andersson LC
    Clin Exp Immunol; 1985 Aug; 61(2):467-74. PubMed ID: 2931228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of toremifene on clinical chemistry, hematology and hormone levels at different doses in healthy postmenopausal volunteers: phase I study.
    Kivinen S; Mäenpää J
    J Steroid Biochem; 1990 Jun; 36(3):217-20. PubMed ID: 2142236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 17beta-estradiol, diethylstilbestrol, tamoxifen, toremifene and ICI 164,384 induce morphological transformation and aneuploidy in cultured Syrian hamster embryo cells.
    Tsutsui T; Taguchi S; Tanaka Y; Barrett JC
    Int J Cancer; 1997 Jan; 70(2):188-93. PubMed ID: 9009159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemosensitizing effect of an antiestrogen, toremifene, on ovarian cancer.
    Mäenpää J; Sipilä P; Kangas L; Karnani P; Grönroos M
    Gynecol Oncol; 1992 Sep; 46(3):292-7. PubMed ID: 1388131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the effects of EM-652 (SCH57068), tamoxifen, toremifene, droloxifene, idoxifene, GW-5638 and raloxifene on the growth of human ZR-75-1 breast tumors in nude mice.
    Gutman M; Couillard S; Roy J; Labrie F; Candas B; Labrie C
    Int J Cancer; 2002 May; 99(2):273-8. PubMed ID: 11979444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.